Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model

NCT04072302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria

Interventions

DRUG: KAF156
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals